# Octarine Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/octarine-bio-aps

- Industry: Biotechnology
- Headquarters: Copenhagen, Denmark
- Website: www.octarinebio.com
- Total disclosed funding: $5.9M
- Latest round: Series A (Dec 23, 2025)
- Investors on record: 7

## About

Octarine Bio ApS is a Danish company specializing in synthetic biology solutions that provide sustainable, bio-based products to meet global challenges, focusing on advanced enzyme technology and precision fermentation processes. Founded in 2018 in Copenhagen, Denmark, Octarine Bio ApS focuses on developing sustainable bioproducts. It was founded by Nethaji Gallage (CEO), and Nick Milne (CSO). In December 2025, Octarine Bio ApS raised EUR 5 million in series A funding from Edaphon, Ginkgo Bioworks, EIFO with participation from The Footprint Firm, Unconventional Ventures, DSM Venturing, and Oskare Capital.  Octarine Bio specializes in synthetic biology solutions, offering advanced enzyme technology and the PurePalette™ precision fermentation process to create custom microbes for various bio-based ingredients. These include textile dyes, skincare components, and health supplements, focusing on reducing environmental impact. Their offerings are relevant to sectors such as textiles, cosmetics, and nutritional supplements, addressing the needs of manufacturers seeking sustainable practices across Europe, North America, and Asia. Octarine Bio generates revenue through strategic partnerships and direct B2B sales, primarily focusing on its flagship PurePalette™ dye products. Collaborating with manufacturers, they integrate these dyes into existing production frameworks, emphasizing sustainability in client supply chains. Pricing structures are tailored according to client requirements, promoting long-term partnerships. Looking ahead, Octarine Bio plans to launch new products leveraging its precision fermentation technology, with specific timelines for integration into existing markets. The company will use the January 2026 funding to accelerate industrial-scale validation and commercial rollout of its natural pigment platform.

## Funding rounds

- Series A, Dec 23, 2025, $5.9M — DSM Venturing, Ginkgo Bioworks, Unconventional Ventures, Oskare Capital, The Footprint Firm, Edaphon, Export and Investment Fund of Denmark

## Investors

- DSM Venturing (https://capitalatlas.ai/funds/dsm-venturing) — Series A
- Ginkgo Bioworks (https://capitalatlas.ai/funds/ginkgo-bioworks) — Series A
- Unconventional Ventures (https://capitalatlas.ai/funds/unconventional-ventures) — Series A
- Oskare Capital (https://capitalatlas.ai/funds/oskare-capital) — Series A
- The Footprint Firm (https://capitalatlas.ai/funds/the-footprint-firm) — Series A
- Edaphon (https://capitalatlas.ai/funds/edaphon) — Series A
- Export and Investment Fund of Denmark (https://capitalatlas.ai/funds/export-and-investment-fund-of-denmark) — Series A